vs
艾伯维（ABBV）与PACS Group, Inc.（PACS）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是PACS Group, Inc.的12.2倍（$16.6B vs $1.4B）。艾伯维净利率更高（10.9% vs 4.4%，领先6.5%）。PACS Group, Inc.同比增速更快（18.4% vs 10.0%）。过去两年PACS Group, Inc.的营收复合增速更高（20.5% vs 16.2%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
ABBV vs PACS — 直观对比
营收规模更大
ABBV
是对方的12.2倍
$1.4B
营收增速更快
PACS
高出8.4%
10.0%
净利率更高
ABBV
高出6.5%
4.4%
两年增速更快
PACS
近两年复合增速
16.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $1.4B |
| 净利润 | $1.8B | $59.7M |
| 毛利率 | 72.6% | — |
| 营业利润率 | 27.3% | 7.0% |
| 净利率 | 10.9% | 4.4% |
| 营收同比 | 10.0% | 18.4% |
| 净利润同比 | 8354.5% | 3022.5% |
| 每股收益（稀释后） | $1.02 | $0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVPACS
| Q4 25 | $16.6B | $1.4B | ||
| Q3 25 | $15.8B | $1.3B | ||
| Q2 25 | $15.4B | $1.3B | ||
| Q1 25 | $13.3B | $1.3B | ||
| Q4 24 | $15.1B | $1.1B | ||
| Q3 24 | $14.5B | $1.0B | ||
| Q2 24 | $14.5B | $981.4M | ||
| Q1 24 | $12.3B | $934.3M |
净利润ABBVPACS
| Q4 25 | $1.8B | $59.7M | ||
| Q3 25 | $186.0M | $52.4M | ||
| Q2 25 | $938.0M | $51.0M | ||
| Q1 25 | $1.3B | $28.5M | ||
| Q4 24 | $-22.0M | $1.9M | ||
| Q3 24 | $1.6B | $15.6M | ||
| Q2 24 | $1.4B | $-10.9M | ||
| Q1 24 | $1.4B | $49.1M |
毛利率ABBVPACS
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | 17.1% | ||
| Q2 24 | 70.9% | 22.3% | ||
| Q1 24 | 66.7% | 21.2% |
营业利润率ABBVPACS
| Q4 25 | 27.3% | 7.0% | ||
| Q3 25 | 12.1% | 6.4% | ||
| Q2 25 | 31.7% | 6.2% | ||
| Q1 25 | 28.0% | 3.8% | ||
| Q4 24 | -9.9% | 1.7% | ||
| Q3 24 | 26.5% | 2.2% | ||
| Q2 24 | 27.6% | 0.1% | ||
| Q1 24 | 22.7% | 8.6% |
净利率ABBVPACS
| Q4 25 | 10.9% | 4.4% | ||
| Q3 25 | 1.2% | 3.9% | ||
| Q2 25 | 6.1% | 3.9% | ||
| Q1 25 | 9.6% | 2.2% | ||
| Q4 24 | -0.1% | 0.2% | ||
| Q3 24 | 10.8% | 1.5% | ||
| Q2 24 | 9.5% | -1.1% | ||
| Q1 24 | 11.1% | 5.3% |
每股收益（稀释后）ABBVPACS
| Q4 25 | $1.02 | $0.42 | ||
| Q3 25 | $0.10 | $0.32 | ||
| Q2 25 | $0.52 | $0.31 | ||
| Q1 25 | $0.72 | $0.17 | ||
| Q4 24 | $-0.03 | $-0.03 | ||
| Q3 24 | $0.88 | $0.10 | ||
| Q2 24 | $0.77 | $-0.07 | ||
| Q1 24 | $0.77 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | $197.0M |
| 总债务越低越好 | $58.9B | $353.2M |
| 股东权益账面价值 | $-3.3B | $946.8M |
| 总资产 | $134.0B | $5.6B |
| 负债/权益比越低杠杆越低 | — | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资ABBVPACS
| Q4 25 | $5.3B | $197.0M | ||
| Q3 25 | $5.7B | $355.7M | ||
| Q2 25 | $6.5B | $294.2M | ||
| Q1 25 | $5.2B | $287.5M | ||
| Q4 24 | $5.6B | $157.7M | ||
| Q3 24 | $7.3B | $49.5M | ||
| Q2 24 | $13.2B | $73.4M | ||
| Q1 24 | $18.1B | $81.2M |
总债务ABBVPACS
| Q4 25 | $58.9B | $353.2M | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | $411.9M | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — | ||
| Q1 24 | $63.8B | — |
股东权益ABBVPACS
| Q4 25 | $-3.3B | $946.8M | ||
| Q3 25 | $-2.6B | $871.3M | ||
| Q2 25 | $-183.0M | $806.8M | ||
| Q1 25 | $1.4B | $750.2M | ||
| Q4 24 | $3.3B | $709.6M | ||
| Q3 24 | $6.0B | $660.0M | ||
| Q2 24 | $6.8B | $572.1M | ||
| Q1 24 | $8.0B | $128.0M |
总资产ABBVPACS
| Q4 25 | $134.0B | $5.6B | ||
| Q3 25 | $133.9B | $5.6B | ||
| Q2 25 | $137.2B | $5.5B | ||
| Q1 25 | $136.2B | $5.5B | ||
| Q4 24 | $135.2B | $5.2B | ||
| Q3 24 | $143.4B | $4.5B | ||
| Q2 24 | $141.9B | $3.9B | ||
| Q1 24 | $148.9B | $3.9B |
负债/权益比ABBVPACS
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | 0.58× | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-3.4M |
| 自由现金流经营现金流 - 资本支出 | $4.9B | — |
| 自由现金流率自由现金流/营收 | 29.4% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 2.87× | -0.06× |
| 过去12个月自由现金流最近4个季度 | $17.8B | — |
8季度趋势，按日历期对齐
经营现金流ABBVPACS
| Q4 25 | $5.2B | $-3.4M | ||
| Q3 25 | $7.0B | $204.8M | ||
| Q2 25 | $5.2B | $52.6M | ||
| Q1 25 | $1.6B | $150.2M | ||
| Q4 24 | $7.0B | $64.6M | ||
| Q3 24 | $5.4B | $209.2M | ||
| Q2 24 | $2.3B | $34.8M | ||
| Q1 24 | $4.0B | $58.8M |
自由现金流ABBVPACS
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $3.8B | — |
自由现金流率ABBVPACS
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 31.3% | — |
资本支出强度ABBVPACS
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率ABBVPACS
| Q4 25 | 2.87× | -0.06× | ||
| Q3 25 | 37.76× | 3.91× | ||
| Q2 25 | 5.49× | 1.03× | ||
| Q1 25 | 1.27× | 5.28× | ||
| Q4 24 | — | 33.78× | ||
| Q3 24 | 3.49× | 13.39× | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
